All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. Use of pneumococcal vaccines in the elderly: an economic evaluation

    KCE Reports 274 (2016) Supplementary material pdf fileR274_Supplementary-file_Univariate-sensitivity-analyses (13.95 MB) pdf fileR274_Supplementary-file_Sensitivity-analyses_PPV23-price (1.1 MB) pdf fileR274_Supplementary-file_Multivariate-sensitivity-analyses_Net-benefit-Box-plots (1.16 MB) pdf fileR274_Supplementary-file_Multivariate-sensitivity-analyses_CEAFs-and-CE-planes (58.74 MB) The results are also available in a searchable spreadsheet-database format for all scenario and sensitivity analyses.

    https://kce.fgov.be/en/use-of-pneumococcal-vaccines-in-the-elderly-an-economic-evaluation

  2. Trastuzumab in Early Stage Breast Cancer

    KCE Reports 34 (2006) 30 June (2nd edition; 22 June 2006, 1st edition)

    https://kce.fgov.be/en/trastuzumab-in-early-stage-breast-cancer

  3. Towards a better managed off-label use of drugs

    KCE Reports 252 (2015)

    https://kce.fgov.be/en/towards-a-better-managed-off-label-use-of-drugs

  4. Tiotropium in the Treatment of Chronic Obstructive Pulmonary Disease: Health Technology Assessment

    KCE Reports 108 (2009)

    https://kce.fgov.be/en/tiotropium-in-the-treatment-of-chronic-obstructive-pulmonary-disease-health-technology-assessment

  5. The long-term efficacy of psychotherapy, alone or in combination with antidepressants, in the treatment of adult major depression

    KCE Reports 230 (2014)

    https://kce.fgov.be/en/the-long-term-efficacy-of-psychotherapy-alone-or-in-combination-with-antidepressants-in-the

  6. Supportive treatment for cancer – Part 3: Treatment of pain: most common practices

    KCE Reports 211 (2013)

    https://kce.fgov.be/en/supportive-treatment-for-cancer-%E2%80%93-part-3-treatment-of-pain-most-common-practices

  7. Supportive treatment for cancer - Part 2: Prevention and treatment of adverse events related to chemotherapy and radiotherapy

    KCE Reports 191 (2012)

    https://kce.fgov.be/en/supportive-treatment-for-cancer-part-2-prevention-and-treatment-of-adverse-events-related-to
  8. Senior couple on contry bike

    Statins for the primary prevention of cardiovascular events

    KCE Reports 306 (2019) A healthy lifestyle remains the most effective way of avoiding cardiovascular diseases and their consequences. Yet since 2002, the annual number of people who use cholesterol-lowering drugs from the statin family increased from 400,000 to 1,500,000. Currently, 25% of the population aged 40 and above take these drugs. Despite decreases in price due to the fact that all statins now exist in generic form, their total cost still stands at 160 million euros annually.

    https://kce.fgov.be/en/statins-for-the-primary-prevention-of-cardiovascular-events

  9. Seamless care with regard to medications between hospital and home

    KCE Reports 131 (2010)

    https://kce.fgov.be/en/seamless-care-with-regard-to-medications-between-hospital-and-home

  10. Publicly funded Practice-oriented Clinical Trials

    KCE Reports 246 (2015)

    https://kce.fgov.be/en/publicly-funded-practice-oriented-clinical-trials
  11. Antibiotic_Policy

    Proposals for a more effective antibiotic policy in Belgium

    KCE Reports 311 (2019)  

    https://kce.fgov.be/en/proposals-for-a-more-effective-antibiotic-policy-in-belgium

  12. Policies for Rare Diseases and Orphan Drugs

    KCE Reports 112 (2009)

    https://kce.fgov.be/en/policies-for-rare-diseases-and-orphan-drugs

  13. Pharmacological prevention of fragility fractures in Belgium

    KCE Reports 159 (2011)

    https://kce.fgov.be/en/pharmacological-prevention-of-fragility-fractures-in-belgium

  14. Pharmacological and surgical treatment of obesity. Residential care for severely obese children in Belgium.

    KCE Reports 36 (2006) August 2006 (3rd edition ; 2nd edition : July 2006 ; 1st edition : June 2006)

    https://kce.fgov.be/en/pharmacological-and-surgical-treatment-of-obesity-residential-care-for-severely-obese-children-in

  15. Pharmaceutical and non-pharmaceutical interventions for Alzheimer’s Disease, a rapid assessment

    KCE Reports 111 (2009)

    https://kce.fgov.be/en/pharmaceutical-and-non-pharmaceutical-interventions-for-alzheimer%E2%80%99s-disease-a-rapid-assessment

  16. Medication use in rest and nursing homes in Belgium.

    KCE Reports 47 (2006)

    https://kce.fgov.be/en/medication-use-in-rest-and-nursing-homes-in-belgium
  17. Pils

    Guideline on the prudent prescription of antibiotics in the dental office

    KCE Reports R332C

    https://kce.fgov.be/en/guideline-on-the-prudent-prescription-of-antibiotics-in-the-dental-office

  18. Future scenarios about drug development and drug pricing

    KCE Reports 271 (2016)

    https://kce.fgov.be/en/future-scenarios-about-drug-development-and-drug-pricing

  19. Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C

    KCE Reports 276 (2016)

    https://kce.fgov.be/en/economic-evaluation-of-novel-direct-acting-antiviral-daa-treatment-strategies-for-chronic-hepatitis

  20. Drug reimbursement systems: international comparison and policy recommendations

    KCE Reports 147 (2010)

    https://kce.fgov.be/en/drug-reimbursement-systems-international-comparison-and-policy-recommendations

Pages